Rezolve AI Ltd (RZLV) concluded trading on Thursday at a closing price of $1.95, with 4.47 million shares of worth about $8.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -80.60% during that period and on February 27, 2025 the price saw a loss of about -10.14%. Currently the company’s common shares owned by public are about 172.18M shares, out of which, 46.37M shares are available for trading.
Stock saw a price change of -24.42% in past 5 days and over the past one month there was a price change of -23.83%. Year-to-date (YTD), RZLV shares are showing a performance of -48.95% which decreased to -82.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.57 but also hit the highest price of $14.50 during that period. The average intraday trading volume for Rezolve AI Ltd shares is 11.58 million. The stock is currently trading -26.30% below its 20-day simple moving average (SMA20), while that difference is down -34.81% for SMA50 and it goes to -71.29% lower than SMA200.
Rezolve AI Ltd (NASDAQ: RZLV) currently have 172.18M outstanding shares and institutions hold larger chunk of about 1.59% of that.
The stock has a current market capitalization of $406.18M and its 3Y-monthly beta is at -0.65. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 0.01 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RZLV, volatility over the week remained 12.84% while standing at 10.66% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on January 16, 2025 offering a Buy rating for the stock and assigned a target price of $10 to it. Coverage by Northland Capital stated Rezolve AI Ltd (RZLV) stock as an Outperform in their note to investors on December 18, 2024, suggesting a price target of $5 for the stock. On December 10, 2024, ROTH MKM Initiated their recommendations, while on December 05, 2024, Cantor Fitzgerald Initiated their ratings for the stock with a price target of $5.